期刊文献+

不同血液病患者巨细胞病毒抗体滴度比较 被引量:2

Comparison of Human Cytomegalovirus Antibody Titer in Various Blood Diseases
下载PDF
导出
摘要 人巨细胞病毒(Human cytomegalovirus,HCMV)是常见的机会性感染病毒,在健康人群中不致病,但机体免疫系统下降时可导致严重的HCMV疾病。目前研究多集中于新生儿和器官移植病人的研究,少有血液疾病HCMV感染的报道。本研究集中于7种血液疾病42例患者,检测其体内抗HCMV-IgG和IgM抗体滴度。结果表明在3种血液肿瘤(急性淋巴细胞白血病、慢性淋巴细胞白血病、慢性粒细胞白血病)中抗体滴度最高,而在其余4种非肿瘤血液疾病中抗体滴度相对较低,表明血液肿瘤对免疫系统的损害高于非肿瘤血液疾病。 Human cytomegalovirus(HCMV) is a common opportunistic pathogen. HCMV is asymptomatic in common persons and could reactive in immunosuppression groups. Current researches focus on newborn babies and organ transplantation patients. A few results have been reported about the HCMV infection status in different blood diseases. In this study, anti HCMV IgG and IgM antibody titers of 42 clinical samples from seven different blood diseases, including Aplastic Anemia (AA), Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia ( CLL), Acute Lymphoblastic I.eukemia ( ALL), Chronic Myeloid Leukemia ( CML ), Iron Deficiency Anemia (IDA) and Pancytopenia(PA) were detected. The results showed that IgC- and IgM titers were higher in three blood tumors (ALL,CLL and CML) than in other non tumor blood diseases(AA, MDS,IDA and PA). Our study demonstrated that immune function was more seriously damaged in blood tumor diseases than in non tumor blood diseases.
出处 《成都医学院学报》 CAS 2013年第1期89-91,共3页 Journal of Chengdu Medical College
关键词 人巨细胞病毒 抗HCMV IgG IGM抗体 抗体滴度 血液疾病 Human cytomegalovirus Anti-HCMV-IgG/IgM antibody Antibody titer Blood diseases
  • 相关文献

参考文献6

  • 1Revello MG, Gerna G. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications[J]. Rev Med Virol,2010,20(3):136-155.
  • 2Vanarsdall AL, Ryckman BJ, Chase MC, et al. Human cytomegalovirus glycoprotein gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans[J]. J Virol,2008,82(23) :11837-11850.
  • 3Tuthill M, Chen F, Paston S, et al. The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation[J]. Cancer Immunol Immunother, 2009, 58(9): 1481-1488.
  • 4李长贵,王剑锋,英志芳,周铁群,李娟.以重组人巨细胞病毒pp65制备的多克隆抗体建立检测感染性病毒颗粒方法[J].中国生物工程杂志,2005,25(10):47-49. 被引量:3
  • 5Wang W, Yu P, Zhang P, et al. The infection of human primary cells and cell lines by human cytomegalovirus: new tropism and new reservoirs for HCMV[J]. Virus research, 131(2) : 160-169.
  • 6Capris S, Gentile G, Capobianehi A, et al. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia[J]. J Med Virol, 2010, 82(7) : 1201-1207.

二级参考文献8

  • 1Boeckh M, Leisenring W, Riddell S R, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood, 2003,101(2) :407 ~414.
  • 2Numata S, Nakamura Y, Imamura Y, et al. Rapid quantitative analysis of human cytomegalovirus DNA by the real-time polymerase chain reaction method. Arch Pathol Lab Med,2005,129(2) :200 ~ 204.
  • 3Gallina A, Percivalle E, Simoncini L, et al. Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals. J Gen Virol, 1996,77 (6) :1151 ~1157.
  • 4St George K, Rinaldo CR Jr. Comparison of commercially available antibody reagents for the cytomegalovirus pp65antigenemia assay. Clin Diagn Virol, 1997, 7(3) :147 ~152.
  • 5奥斯伯FM 布伦特R金斯顿RE etal 颜子颖 译.精编分子生物学试验指南[M].科学出版社,1998..
  • 6Arcangeletti M C, De Conto F, Ferraglia F, et al. Human cytomegalovirus proteins PP65 and IEP72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts. J Cell Biochem, 2003, 90 ( 5 ):1056 ~ 1067.
  • 7Chee M S, Bankier A T, Beck S, et al. Analysis of the proteincoding content of the sequence of human cytomegalovirus strain AD169. Current Topics in Microbiology and Immunology,1990, 154:125 ~ 169.
  • 8Ausubel F M, Brent R, Kingston R E, et al. Short protocols in Molecular Biology. 3ed. New York: John Wiley & Sons,Inc. ,1995. 432~434.

共引文献2

同被引文献18

  • 1丁艳,贾德胜,梅红,黄志华.特发性血小板减少性紫癜患儿骨髓巨细胞病毒抗原的检测及临床价值[J].临床儿科杂志,2007,25(7):547-550. 被引量:7
  • 2Crough T,Khanna R.Immunobiology of human cytomegalovirus: from bench to bedside[J].Clin Microbiol Rev,2009,22(1):76-98.
  • 3Thorley-Lawson,JB Hawkins,SI Tracy,et al.The pathogenesis of Epstein-Barr virus persistent infection[J].Curr Opin Virol,2013,3(3):227-232.
  • 4Thorley-Lawson,MJ Allday.The curious case of the tumour vi-rus:50 years of Burkitt,s lymphoma[J].Nat Rev Microbiol,2008,6(12):913-924.
  • 5Thorley-Lawson DA,Duca KA.Epatein-Barr virus:a paradigm for persistent infection-for real and in virtual reality[J].Trends Immunol,2008,29(2):195-201.
  • 6Fachiroh J,Paramita B Hariwiyanto.Single-assay combination of Epstein-Barr Virus(EBV)EBNA-I and viral capsid antigen-pl8-derived synthetic peptides for measuring anti-EBV immunoglobu-lin G(IgG)and IgA antibody levels in sera from nasopharyngeal carcinoma patients:options for field screening[J].J Clin Microbi-ol,2006,44(14):1459-1467.
  • 7Macsween K,Crawford H.Epstein Barr virus recent advances[J].Lancet Infect Dis,2003,3(1):131-133.
  • 8Gupta VR,Pratap AK.Epidemiological Features of Aplastic Ane-mia in Indian Children[J],Indian J Pediatr,2013,81(3):257-259.
  • 9Ahmed HG,Osman M.Ashankyty.Incidence of Epstein-Barr vi-rus in pediatric leukemia in the Sudan[J].Clin Lymphoma Myelo ma Leuk,2012,12(2):127-131.
  • 10Sinclair JH, Reeves MB.Human cytomegalovirus manipulation of latently infected cells[J].Viruses,2013,5(11):2803-2805.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部